GL Ventures

All recorded activity

By stage

Series B2

Undisclosed2

Biotech2

AI1

Hardware1

United States2

China1

Singapore1

4 in all activity

May 6

Develops immunotherapies to harness myeloid biology for cancer treatment

$38MUndisclosed

Role not disclosed

Apr 3

Develops intelligent platform-driven macrocyclic peptide drug discovery

$150MSeries B

Role not disclosed

Mar 9

Helps teams build deploy and operate production-grade AI applications and agentic workflows

$30MPre-Series A

Role not disclosed

Jan 27

Provides modular and prefabricated data center infrastructure

$100MSeries B

Role not disclosed